Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption.
Fukuda M, Wakamatsu-Yamanaka T, Mizuno M, Miura T, Tomonari T, Kato Y, Ichikawa T, Miyagi S, Shirasawa Y, Ito A, Yoshida A, Kimura G. Fukuda M, et al. Among authors: yoshida a. Am J Physiol Renal Physiol. 2011 Nov;301(5):F953-7. doi: 10.1152/ajprenal.00167.2011. Epub 2011 Aug 24. Am J Physiol Renal Physiol. 2011. PMID: 21865265 Free article.
Recently, we found that an angiotensin II receptor blocker (ARB) restored the circadian rhythm of the blood pressure (BP) from a nondipper to a dipper pattern, similar to that achieved with sodium intake restriction and diuretics (Fukuda M, Yamanaka T, Mizuno M, Mot …
Recently, we found that an angiotensin II receptor blocker (ARB) restored the circadian rhythm of the blood pressure (BP) from a nond …
Morning hypertension in chronic kidney disease is sustained type, but not surge type.
Mizuno M, Fukuda M, Miura T, Wakamatsu T, Naito T, Sato R, Togawa H, Sasakawa Y, Tomonari T, Ono M, Kato Y, Ichikawa T, Shirasawa Y, Ito A, Yoshida A, Kimura G. Mizuno M, et al. Among authors: yoshida a. Blood Press Monit. 2012 Feb;17(1):20-3. doi: 10.1097/MBP.0b013e32835026c6. Blood Press Monit. 2012. PMID: 22218220
Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan.
Ono M, Fukuda M, Miura T, Mizuno M, Kato Y, Sato R, Naito T, Togawa H, Sasakawa Y, Tomonari T, Ichikawa T, Shirasawa Y, Ito A, Yoshida A, Kimura G. Ono M, et al. Among authors: yoshida a. J Renin Angiotensin Aldosterone Syst. 2012 Jun;13(2):239-43. doi: 10.1177/1470320311434817. Epub 2012 Feb 14. J Renin Angiotensin Aldosterone Syst. 2012. PMID: 22333486 Free article. Clinical Trial.
Circadian rhythm of urinary potassium excretion in patients with CKD.
Miura T, Fukuda M, Naito T, Togawa H, Sato R, Sasagawa Y, Tomonari T, Kato Y, Mizuno M, Ono M, Ichikawa T, Shirasawa Y, Ito A, Yoshida A, Kimura G. Miura T, et al. Among authors: yoshida a. Clin Nephrol. 2012 Sep;78(3):169-73. doi: 10.5414/cn107399. Clin Nephrol. 2012. PMID: 22874104
Circadian rhythm of urinary potassium excretion during treatment with an angiotensin receptor blocker.
Ogiyama Y, Miura T, Watanabe S, Fuwa D, Tomonari T, Ota K, Kato Y, Ichikawa T, Shirasawa Y, Ito A, Yoshida A, Fukuda M, Kimura G. Ogiyama Y, et al. Among authors: yoshida a. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):509-14. doi: 10.1177/1470320313475909. Epub 2013 Feb 6. J Renin Angiotensin Aldosterone Syst. 2014. PMID: 23390190 Free article. Clinical Trial.
4,220 results